Notice on expected shortage of Cefepime Kabi powder for solution for injection or infusion (cefepime)
16.11.2015
Fresenius Kabi d.o.o., the marketing authorisation holder for Cefepime Kabi powder for solution for injection or infusion (cefepime) à 1 and 2 g, has notified the Agency for Medicinal Products and Medical devices (HALMED) of an expected shortage of these medicinal products on the Croatian market.
more